MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Increased alpha-internexin levels are associated with a higher risk of Parkinson’s disease

X. Guo, G. Tian, R. Zhou, R. Li (Xi'an, China)

Meeting: 2024 International Congress

Abstract Number: 1641

Keywords: Parkinson’s

Category: Parkinson's Disease: Genetics

Objective: This study aims to evaluate the causal relationship between plasma alpha-internexin levels and the risk of Parkinson’s disease (PD).

Background: Alpha-internexin, implicated in neuronal development and axonal outgrowth, is a neuronal-specific intermediate filament protein widely expressed in the central nervous system. Previous studies have suggested that overexpression of alpha-internexin is related to motor coordination deficits and involved in several neurodegenerative diseases. However, whether alpha-internexin levels are causally associated with PD is largely unknown.

Method: We conducted a two-sample Mendelian randomization (MR) study to evaluate the causal relationship between alpha-internexin levels and the risk of PD. The summary-level data for plasma alpha-internexin levels (id: “prot-a-1551”) and PD (id: “ieu-b-2”) used in this MR study were retrieved from the OpenGWAS using the TwosampleMR package (version 0.5.7) in R software (version 4.3.2) [1]. There were seven instrumental variables available for alpha-internexin levels (P<5E-06). Five different statistical methods were used to calculate the MR estimates. Pleiotropy and heterogeneity analyses were performed to confirm the robustness of the findings.

Results: The MR estimate using the inverse variance weighted (IVW) method showed that plasma alpha-internexin levels were causally linked to a higher risk of PD (OR=1.22, 95%CI=1.05-1.43, P= 0.009). Sensitivity analysis using other approaches showed similar results with the same trend (Figure 1). No obvious horizontal pleiotropy or heterogeneity was found in the MR-Egger test or Cochran’s Q test, indicating good reliability.

Conclusion: The present MR study demonstrates that higher plasma alpha-internexin levels are causally associated with an increased risk of PD, which might serve as a potential biomarker for PD.

Figure 1

Figure 1

References: 1. Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V, Baird D, Laurin C, Burgess S, Bowden J, Langdon R: The MR-Base platform supports systematic causal inference across the human phenome. elife 2018, 7:e34408.

To cite this abstract in AMA style:

X. Guo, G. Tian, R. Zhou, R. Li. Increased alpha-internexin levels are associated with a higher risk of Parkinson’s disease [abstract]. Mov Disord. 2024; 39 (suppl 1). https://www.mdsabstracts.org/abstract/increased-alpha-internexin-levels-are-associated-with-a-higher-risk-of-parkinsons-disease/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2024 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/increased-alpha-internexin-levels-are-associated-with-a-higher-risk-of-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley